Bighead carp (Hypophthalmichthys nobilis) and silver carp (H. molitrix), collectively referred to as bigheaded carps, are cyprinids native primarily to China and have been launched to over 70 nations. Paleontological and molecular phylogenetic analyses exhibit bighead and silver carps originated from the Yangtze-Huanghe River basins and trendy populations could have derived from the secondary contact of geographically remoted fish over the past glacial occasions. Important genetic variations are discovered amongst populations of native rivers (Yangtze, Pearl, and Amur) in addition to launched/invasive environments (Mississippi R., USA and Danube R., Hungary), suggesting genetic backgrounds and ecological choice could play a job in inhabitants differentiation.
Inhabitants divergence of bighead carp or silver carp has occurred inside their native rivers, whereas, throughout the Mississippi River Basin (MRB)-an launched area, such genetic differentiation is probably going going down at the least in silver carp. Interspecific hybridization between silver and bighead carps is uncommon inside their native areas; nevertheless, intensive hybridization is noticed within the MRB, which could possibly be contributed by a shift to a extra homogenous setting that lacks reproductive isolation limitations for the restriction of gene move between species.
The wild populations of native bighead and silver carps have skilled dramatic declines; in distinction, the launched bigheaded carps overpopulate the MRB and are thought-about two invasive species, which strongly suggests fishing capability (overfishing and underfishing) be a decisive issue for fishery useful resource exploitation and administration. This assessment offers not solely a world perspective of evolutionary historical past and inhabitants divergence of bigheaded carps but additionally a discussion board that requires worldwide analysis collaborations to take care of essential points associated to native inhabitants conservation and invasive species management.
A brand new genus of pliopithecoid from the late Early Miocene of China and its implications for understanding the paleozoogeography of the Pliopithecoidea
A variety of pliopithecoids is thought from Miocene localities in Europe, however till just lately, this group was comparatively poorly represented in China. Nonetheless, new discoveries have proven that Chinese language pliopithecoids have been taxonomically various and geographically widespread. The earliest pliopithecoids in China (and Eurasia) are Dionysopithecus and Platodontopithecus from the Early Miocene of Sihong, Jiangsu (∼19-18 Ma). Throughout the Center Miocene (∼15-12 Ma), a number of species of pliopithecoids are recorded at localities in Gansu Province (Laogou), Internal Mongolia (Damiao), Xinjiang Uygur Autonomous Area (Tieersihabahe), and Ningxia Hui Autonomous Area (Tongxin).
Lastly, a late-surviving anapithecine crouzeliid, Laccopithecus robustus, is thought from the Late Miocene (∼7 Ma) of Shihuiba in Yunnan, which postdates the extinction of pliopithecoids in Europe (throughout MN 10). Paleontological investigations at a late Early Miocene locality close to Fanchang in Anhui Province have yielded a big pattern of remoted enamel (a couple of hundred) of a beforehand unknown species of pliopithecoid. The related micromammals point out an age contemporaneous with the Shanwang Formation in Shandong Province (MN 3-4, ∼18-17 Ma). All the everlasting enamel are represented aside from I2.
With its distinctive suite of dental options, the Fanchang pliopithecoid might be attributed to a brand new species and genus. Shared derived options of the decrease molars affirm that the Fanchang pliopithecoid has its closest affinities with European crouzeliids, however quite a few primitive traits point out that it’s a stem member of the clade. The proof factors to China as an vital heart for the early diversification of pliopithecoids. Opposite to earlier zoogeographic eventualities, the prevalence of an early crouzeliid in China implies that the Pliopithecidae and Crouzeliidae could have diverged from a stem pliopithecoid in Asia in the course of the Early Miocene earlier than their arrival in Europe.
Radiographic evaluation and digital cleansing of a bioarchaeological stay enclosed in mineral deposits from a limestone cave
In limestone caves, environmental processes usually trigger alterations of human or animal skeletal stays, complicating classical analytical strategies. Exemplary, a proximal femoral skeletal fragment, enclosed by a thick layer of speleothemic calcite deposits, was found in the course of the exploration of the Bedara collapse Žumberak, Croatia. An examination with out elimination of the encompassing mineral deposits, presumably main to break of the specimen, was, subsequently, fascinating.We describe and talk about the utilized methods, together with medical computed tomography, digital cleansing by a specifically developed segmentation protocol utilizing an open-source DICOM viewer, and digital visualisation and dimensioning utilizing computer-aided design software program, in order that this “hidden” specimen could possibly be non-invasively examined in nice element.
 A1CF antibody |
|||
| 70R-4765 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal A1CF antibody raised against the N terminal of A1CF |
|||
A1CF antibody |
|||
| 70R-4770 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal A1CF antibody raised against the N terminal of A1CF |
|||
 anti-A1CF |
|||
| YF-PA18666 | Abfrontier | 50 ul | EUR 363 |
|
Description: Mouse polyclonal to A1CF |
|||
anti-A1CF |
|||
| YF-PA18667 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to A1CF |
|||
 A1CF Antibody |
|||
| 39439-100ul | SAB | 100ul | EUR 390 |
 A1CF Blocking Peptide |
|||
| 33R-2286 | Fitzgerald | 100 ug | EUR 180 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of A1CF antibody, catalog no. 70R-4765 |
|||
A1CF Blocking Peptide |
|||
| 33R-5962 | Fitzgerald | 100 ug | EUR 180 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of A1CF antibody, catalog no. 70R-4770 |
|||
 A1CF cloning plasmid |
|||
| CSB-CL001002HU1-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the A1CF gene. |
|||
A1CF cloning plasmid |
|||
| CSB-CL001002HU2-10ug | Cusabio | 10ug | EUR 376 |
|
Description: A cloning plasmid for the A1CF gene. |
|||
 A1CF Rabbit pAb |
|||
| A13087-100ul | Abclonal | 100 ul | EUR 308 |
A1CF Rabbit pAb |
|||
| A13087-200ul | Abclonal | 200 ul | EUR 459 |
A1CF Rabbit pAb |
|||
| A13087-20ul | Abclonal | 20 ul | EUR 183 |
A1CF Rabbit pAb |
|||
| A13087-50ul | Abclonal | 50 ul | EUR 223 |
 Anti-A1CF antibody |
|||
| STJ115054 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: Mammalian apolipoprotein B mRNA undergoes site-specific C to U deamination, which is mediated by a multi-component enzyme complex containing a minimal core composed of APOBEC-1 and a complementation factor encoded by this gene. The gene product has three non-identical RNA recognition motifs and belongs to the hnRNP R family of RNA-binding proteins. It has been proposed that this complementation factor functions as an RNA-binding subunit and docks APOBEC-1 to deaminate the upstream cytidine. Studies suggest that the protein may also be involved in other RNA editing or RNA processing events. Several transcript variants encoding a few different isoforms have been found for this gene. |
|||
 A1CF Polyclonal Antibody |
|||
| 27891-100ul | SAB | 100ul | EUR 252 |
A1CF Polyclonal Antibody |
|||
| 27891-50ul | SAB | 50ul | EUR 187 |
 A1CF ELISA KIT|Human |
|||
| EF004624 | Lifescience Market | 96 Tests | EUR 689 |
) A1CF Recombinant Protein (Human) |
|||
| RP000004 | ABM | 100 ug | Ask for price |
A1CF Recombinant Protein (Human) |
|||
| RP036346 | ABM | 100 ug | Ask for price |
) A1CF Recombinant Protein (Mouse) |
|||
| RP112937 | ABM | 100 ug | Ask for price |
) A1CF Recombinant Protein (Rat) |
|||
| RP188426 | ABM | 100 ug | Ask for price |
 Rat A1CF shRNA Plasmid |
|||
| 20-abx987632 | Abbexa |
|
|
 Mouse A1CF shRNA Plasmid |
|||
| 20-abx977075 | Abbexa |
|
|
 Human A1CF shRNA Plasmid |
|||
| 20-abx959309 | Abbexa |
|
|
 A1CF Polyclonal Conjugated Antibody |
|||
| C27891 | SAB | 100ul | EUR 397 |
 (pORF)) A1cf ORF Vector (Rat) (pORF) |
|||
| ORF062810 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) A1CF ORF Vector (Human) (pORF) |
|||
| ORF000002 | ABM | 1.0 ug DNA | EUR 95 |
A1CF ORF Vector (Human) (pORF) |
|||
| ORF012116 | ABM | 1.0 ug DNA | EUR 354 |
 (pORF)) A1cf ORF Vector (Mouse) (pORF) |
|||
| ORF037647 | ABM | 1.0 ug DNA | EUR 506 |
 Antibody) APOBEC1 Complementation Factor (A1CF) Antibody |
|||
| abx038090-100ug | Abbexa | 100 ug | EUR 391 |
 (OKEI00351)) A1CF ELISA Kit (Mouse) (OKEI00351) |
|||
| OKEI00351 | Aviva Systems Biology | 96 Wells | EUR 663 |
|
Description: Description of target: Essential component of the apolipoprotein B mRNA editing enzyme complex which is responsible for the postranscriptional editing of a CAA codon for Gln to a UAA codon for stop in APOB mRNA. Binds to APOB mRNA and is probably responsible for docking the catalytic subunit, APOBEC1, to the mRNA to allow it to deaminate its target cytosine. The complex also seems to protect the edited APOB mRNA from nonsense-mediated decay.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 18.75 pg/mL |
|||
) A1cf sgRNA CRISPR Lentivector set (Rat) |
|||
| K6946101 | ABM | 3 x 1.0 ug | EUR 339 |
) A1CF sgRNA CRISPR Lentivector set (Human) |
|||
| K0013501 | ABM | 3 x 1.0 ug | EUR 339 |
) A1cf sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3848601 | ABM | 3 x 1.0 ug | EUR 339 |
 Human APOBEC1 complementation factor, A1CF ELISA KIT |
|||
| ELI-12253h | Lifescience Market | 96 Tests | EUR 824 |
 A1CF 3'UTR Luciferase Stable Cell Line |
|||
| TU000003 | ABM | 1.0 ml | EUR 1394 |
 A1cf 3'UTR Luciferase Stable Cell Line |
|||
| TU101042 | ABM | 1.0 ml | Ask for price |
 A1cf 3'UTR GFP Stable Cell Line |
|||
| TU151042 | ABM | 1.0 ml | Ask for price |
A1cf 3'UTR Luciferase Stable Cell Line |
|||
| TU200002 | ABM | 1.0 ml | Ask for price |
A1cf 3'UTR GFP Stable Cell Line |
|||
| TU250002 | ABM | 1.0 ml | Ask for price |
 A1CF 3'UTR GFP Stable Cell Line |
|||
| TU050003 | ABM | 1.0 ml | EUR 1394 |
 (pPB-C-His)) A1CF Protein Vector (Mouse) (pPB-C-His) |
|||
| PV150586 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) A1CF Protein Vector (Mouse) (pPB-N-His) |
|||
| PV150587 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) A1CF Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV150588 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) A1CF Protein Vector (Mouse) (pPM-C-His) |
|||
| PV150589 | ABM | 500 ng | EUR 603 |
 (pPB-C-His)) A1CF Protein Vector (Rat) (pPB-C-His) |
|||
| PV251238 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) A1CF Protein Vector (Rat) (pPB-N-His) |
|||
| PV251239 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) A1CF Protein Vector (Rat) (pPM-C-HA) |
|||
| PV251240 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) A1CF Protein Vector (Rat) (pPM-C-His) |
|||
| PV251241 | ABM | 500 ng | EUR 603 |
 (pPB-His-MBP)) A1CF Protein Vector (Human) (pPB-His-MBP) |
|||
| PV318482 | ABM | 500 ng | EUR 329 |
 (pPB-His-GST)) A1CF Protein Vector (Human) (pPB-His-GST) |
|||
| PV318483 | ABM | 500 ng | EUR 329 |
A1CF Protein Vector (Human) (pPB-His-MBP) |
|||
| PV318486 | ABM | 500 ng | EUR 481 |
A1CF Protein Vector (Human) (pPB-His-GST) |
|||
| PV318487 | ABM | 500 ng | EUR 481 |
 (pPB-C-His)) A1CF Protein Vector (Human) (pPB-C-His) |
|||
| PV000005 | ABM | 500 ng | EUR 329 |
 (pPB-N-His)) A1CF Protein Vector (Human) (pPB-N-His) |
|||
| PV000006 | ABM | 500 ng | EUR 329 |
 (pPM-C-HA)) A1CF Protein Vector (Human) (pPM-C-HA) |
|||
| PV000007 | ABM | 500 ng | EUR 329 |
 (pPM-C-His)) A1CF Protein Vector (Human) (pPM-C-His) |
|||
| PV000008 | ABM | 500 ng | EUR 329 |
 Mouse APOBEC1 complementation factor, A1cf ELISA KIT |
|||
| ELI-35057m | Lifescience Market | 96 Tests | EUR 865 |
 (Target 1)) A1cf sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6946102 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) A1cf sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6946103 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) A1cf sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6946104 | ABM | 1.0 ug DNA | EUR 154 |
A1CF Protein Vector (Human) (pPB-C-His) |
|||
| PV048461 | ABM | 500 ng | EUR 481 |
A1CF Protein Vector (Human) (pPB-N-His) |
|||
| PV048462 | ABM | 500 ng | EUR 481 |
A1CF Protein Vector (Human) (pPM-C-HA) |
|||
| PV048463 | ABM | 500 ng | EUR 481 |
A1CF Protein Vector (Human) (pPM-C-His) |
|||
| PV048464 | ABM | 500 ng | EUR 481 |
 (Target 1)) A1CF sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0013502 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) A1CF sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0013503 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) A1CF sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0013504 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 1)) A1cf sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3848602 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) A1cf sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3848603 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) A1cf sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3848604 | ABM | 1.0 ug DNA | EUR 154 |
 ELISA Kit) Human APOBEC1 Complementation Factor (A1CF) ELISA Kit |
|||
| abx384593-96tests | Abbexa | 96 tests | EUR 911 |
 ELISA Kit) Mouse APOBEC1 Complementation Factor (A1CF) ELISA Kit |
|||
| abx388595-96tests | Abbexa | 96 tests | EUR 668 |
 ELISA Kit) Rat APOBEC1 Complementation Factor (A1CF) ELISA Kit |
|||
| abx390981-96tests | Abbexa | 96 tests | EUR 911 |
 (CMV) (pLenti-GIII-CMV)) A1CF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV702531 | ABM | 1.0 ug DNA | EUR 450 |
 (UbC) (pLenti-GIII-UbC)) A1CF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV702535 | ABM | 1.0 ug DNA | EUR 450 |
 (EF1a) (pLenti-GIII-EF1a)) A1CF Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV702536 | ABM | 1.0 ug DNA | EUR 450 |
 (CMV) (pLenti-GIII-CMV)) A1CF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV671083 | ABM | 1.0 ug DNA | EUR 682 |
 (UbC) (pLenti-GIII-UbC)) A1CF Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV671087 | ABM | 1.0 ug DNA | EUR 682 |
 (EF1a) (pLenti-GIII-EF1a)) A1CF Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV671088 | ABM | 1.0 ug DNA | EUR 682 |
 A1cf ELISA Kit| Rat APOBEC1 complementation factor ELISA Kit |
|||
| EF018334 | Lifescience Market | 96 Tests | EUR 689 |
 A1cf ELISA Kit| Mouse APOBEC1 complementation factor ELISA Kit |
|||
| EF014220 | Lifescience Market | 96 Tests | EUR 689 |
 (pPM-N-D-C-HA)) A1CF Protein Vector (Human) (pPM-N-D-C-HA) |
|||
| PV318484 | ABM | 500 ng | EUR 552 |
 (pPM-N-D-C-His)) A1CF Protein Vector (Human) (pPM-N-D-C-His) |
|||
| PV318485 | ABM | 500 ng | EUR 552 |
A1CF Protein Vector (Human) (pPM-N-D-C-HA) |
|||
| PV318488 | ABM | 500 ng | EUR 552 |
A1CF Protein Vector (Human) (pPM-N-D-C-His) |
|||
| PV318489 | ABM | 500 ng | EUR 552 |
) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6946105 | ABM | 3 x 1.0 ug | EUR 376 |
) A1CF sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0013505 | ABM | 3 x 1.0 ug | EUR 376 |
) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3848605 | ABM | 3 x 1.0 ug | EUR 376 |
 (CMV) (pLenti-GIII-CMV-C-term-HA)) A1CF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV702532 | ABM | 1.0 ug DNA | EUR 450 |
 (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)) A1CF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV702533 | ABM | 1.0 ug DNA | EUR 508 |
 (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)) A1CF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV702534 | ABM | 1.0 ug DNA | EUR 508 |
 (CMV) (pLenti-GIII-CMV-C-term-HA)) A1CF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV671084 | ABM | 1.0 ug DNA | EUR 682 |
 (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)) A1CF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV671085 | ABM | 1.0 ug DNA | EUR 740 |
 (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)) A1CF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV671086 | ABM | 1.0 ug DNA | EUR 740 |
 (Target 1)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6946106 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6946107 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6946108 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 1)) A1CF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0013506 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) A1CF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0013507 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) A1CF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0013508 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 1)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3848606 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3848607 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) A1cf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3848608 | ABM | 1.0 ug DNA | EUR 167 |
 Custom siRNA |
|||
| M1253-10 | Biovision | EUR 555 | |
Custom siRNA |
|||
| M1253-2 | Biovision | EUR 311 | |
Custom siRNA |
|||
| M1253-3 | Biovision | EUR 338 | |
Custom siRNA |
|||
| M1253-4 | Biovision | EUR 365 | |
Custom siRNA |
|||
| M1253-5 | Biovision | EUR 446 | |
Custom siRNA |
|||
| M1253-6 | Biovision | EUR 457 | |
Custom siRNA |
|||
| M1253-7 | Biovision | EUR 474 | |
Custom siRNA |
|||
| M1253-8 | Biovision | EUR 495 | |
Custom siRNA |
|||
| M1253-9 | Biovision | EUR 528 | |
 TRAF7 siRNA |
|||
| 20-abx937919 | Abbexa |
|
|
 TRAFD1 siRNA |
|||
| 20-abx937920 | Abbexa |
|
|
TRAFD1 siRNA |
|||
| 20-abx937921 | Abbexa |
|
|
 TRAIP siRNA |
|||
| 20-abx937922 | Abbexa |
|
|
TRAIP siRNA |
|||
| 20-abx937923 | Abbexa |
|
|
 TRAK1 siRNA |
|||
| 20-abx937924 | Abbexa |
|
|
TRAK1 siRNA |
|||
| 20-abx937925 | Abbexa |
|
|
 TRAK2 siRNA |
|||
| 20-abx937926 | Abbexa |
|
|
TRAK2 siRNA |
|||
| 20-abx937927 | Abbexa |
|
|
 TRAM1L1 siRNA |
|||
| 20-abx937928 | Abbexa |
|
|
TRAM1L1 siRNA |
|||
| 20-abx937929 | Abbexa |
|
|
 TRAM1 siRNA |
|||
| 20-abx937930 | Abbexa |
|
|
TRAM1 siRNA |
|||
| 20-abx937931 | Abbexa |
|
|
 TRAM2 siRNA |
|||
| 20-abx937932 | Abbexa |
|
|
TRAM2 siRNA |
|||
| 20-abx937933 | Abbexa |
|
|
 TRANK1 siRNA |
|||
| 20-abx937934 | Abbexa |
|
|
TRANK1 siRNA |
|||
| 20-abx937935 | Abbexa |
|
|
 TRAP1A siRNA |
|||
| 20-abx937936 | Abbexa |
|
|
 TRAP1 siRNA |
|||
| 20-abx937937 | Abbexa |
|
|
TRAP1 siRNA |
|||
| 20-abx937938 | Abbexa |
|
|
 TRAPPC10 siRNA |
|||
| 20-abx937939 | Abbexa |
|
|
 TRAPPC11 siRNA |
|||
| 20-abx937940 | Abbexa |
|
|
TRAPPC11 siRNA |
|||
| 20-abx937941 | Abbexa |
|
|
 TRAPPC12 siRNA |
|||
| 20-abx937942 | Abbexa |
|
|
TRAPPC12 siRNA |
|||
| 20-abx937943 | Abbexa |
|
|
 TRAPPC13 siRNA |
|||
| 20-abx937944 | Abbexa |
|
|
TRAPPC13 siRNA |
|||
| 20-abx937945 | Abbexa |
|
|
 TRAPPC1 siRNA |
|||
| 20-abx937946 | Abbexa |
|
|
TRAPPC1 siRNA |
|||
| 20-abx937947 | Abbexa |
|
|
 TRAPPC2L siRNA |
|||
| 20-abx937948 | Abbexa |
|
|
TRAPPC2L siRNA |
|||
| 20-abx937949 | Abbexa |
|
|
 TRAPPC2P1 siRNA |
|||
| 20-abx937950 | Abbexa |
|
|
 TRAPPC2 siRNA |
|||
| 20-abx937951 | Abbexa |
|
|
TRAPPC2 siRNA |
|||
| 20-abx937952 | Abbexa |
|
|
 TRAPPC3L siRNA |
|||
| 20-abx937953 | Abbexa |
|
|
TRAPPC3L siRNA |
|||
| 20-abx937954 | Abbexa |
|
|
 TRAPPC3 siRNA |
|||
| 20-abx937955 | Abbexa |
|
|
TRAPPC3 siRNA |
|||
| 20-abx937956 | Abbexa |
|
|
 TRAPPC4 siRNA |
|||
| 20-abx937957 | Abbexa |
|
|
TRAPPC4 siRNA |
|||
| 20-abx937958 | Abbexa |
|
|
We additionally report on the circumstances and origin of the discover, the outcomes of radiocarbon courting, and its anatomical and taxonomic identification, in response to which, the bone fragment belonged to a wild boar (Sus scrofa) from the timeframe of the Center Eneolithic Retz-Gajary tradition within the area (4,781 ± 35 years earlier than current). This research offers a reference for future paleontological and anthropological analyses, searching for to unlock the big potential of anatomical research of comparable skeletal stays which might be both petrified or enclosed in speleothemic deposits.